Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Conditions: Multiple Myeloma; Light Chain Nephropathy; Acute Kidney Injury
Interventions: Procedure: Plasma exchange; Drug: Daratumumab
Sponsors: Brigham and Women’s Hospital; Janssen, LP; Baystate Health; Boston Medical Center; Dana-Farber Cancer Institute; Massachusetts General Hospital; Mayo Clinic; M.D. Anderson Cancer Center; Medical University of South Carolina; H. Lee Moffitt Cancer Center and Research Institute; Icahn School of Medicine at Mount Sinai; Northwell Health; Ochsner Health System; Ohio State University; Stanford University; Texas Medical Center; Thomas Jefferson University; University of Alabama at Birmingham; University of California, Los Angeles; University of Chicago; University of Colorado Health; University of Minnesota; University of New Mexico; University of Pennsylvania; University of Pittsburgh; University of Virginia; University of Washington
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 4, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments